HLX6018
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HLX6018, covering 2025-09-19 to 2025-09-19. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation Phase I Clinical Study to Assess the Safety, Pharmacokinetics, and Immunogenicity of HLX6018 in Healthy Subjects [Phase 1]